Recent studies show that FDA-approved antiretroviral FTC/TAF may slow aging by reducing retrotransposon activity, highlighting a promising gerotherapeutic approach with broad accessibility. Groundbrea...
Aging research is pivoting from lifespan extension to enhancing healthspan, with innovations like senolytic drugs and digital health tools transforming clinical practices. Recent geroscience advances ...
Recent Yale studies show that optimistic age beliefs correlate with a 40% memory boost and 30% faster walking speed in older adults, reshaping geroscience approaches. New research reveals that positiv...
Recent research indicates that nearly half of older adults can defy age-related decline through positive beliefs and structured interventions, enhancing cognitive and physical function. New studies re...
Recent research reveals that depleting gut microbiota in aged mice improves brain structure and function, highlighting the gut-brain axis as a key target for anti-aging therapies. Manipulating gut mic...
Recent ethical debates in longevity science highlight public support for life extension with equity, expert calls for transparency, and policy integration to address ageism and access disparities. Adv...
Analytical exploration of how geroscience, epigenetic reprogramming, and AI-driven therapies are converging to extend healthspan, with insights on clinical trials, societal impacts, and future trends....
Biotech advancements in thymus regeneration, like TECregen’s therapies, show promise in rejuvenating immune function for aging populations, addressing delivery challenges and ethical considerati...
Recent studies reveal GDF3’s role in driving inflammation in aging fat tissue, with new therapies targeting the SMAD2/3 axis showing promise for improving metabolic health and extending healthsp...
